Wilms' tumor natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(28 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Wilms' tumor}}
{{Wilms' tumor}}
{{CMG}}
{{CMG}}; {{AE}} {{SSW}}
 


==Overview==
==Overview==
==Natural History==
The symptoms of wilms tumor usually develop in the first decade of life, and start with symptoms such as an [[Abdominal mass|abdominal/flank mass]]. If left untreated, patients with wilms tumor may progress to develop [[hypertension]], [[anemia]], [[weight loss]], [[Renal insufficiency|renal failure]] and [[metastasis]]. The overall 5-year [[survival rate]] is approximately 63% for patients aged 10 to 16 years. Depending on various factors at the time of diagnosis, the [[prognosis]] may vary. These factors are [[histology]] of tumor, stage of tumor, [[Genetics|genetic]] and [[Molecular marker|molecular markers]] and age of the patient.


==Complications==
==Natural History, Complications, and Prognosis==
The tumor may become quite large, but usually remains self-enclosed. Spread of the tumor to the lungs, liver, bone, or brain is the most worrisome complication.


High blood pressure and kidney damage may occur as the result of the tumor or its treatment.
=== Natural History ===
* The symptoms of wilms tumor usually develop in the first decade of life, and start with symptoms such as an abdominal/flank mass.
* If left untreated, patients with wilms tumor may progress to develop hypertension, anemia, weight loss, renal failure and metastasis.
* The overall 5-year survival rate is approximately 63% for patients aged 10 to 16 years.  


Removal of Wilms tumor from both kidneys may affect kidney function.
===Complications===
*Common complications of wilms tumor include:
**Hypertension
**Anu
**Anemia
**Weight loss
**Renal failure
**Metastasis to:<ref name="pmid21384541">{{cite journal |vauthors=Termuhlen AM, Tersak JM, Liu Q, Yasui Y, Stovall M, Weathers R, Deutsch M, Sklar CA, Oeffinger KC, Armstrong G, Robison LL, Green DM |title=Twenty-five year follow-up of childhood Wilms tumor: a report from the Childhood Cancer Survivor Study |journal=Pediatr Blood Cancer |volume=57 |issue=7 |pages=1210–6 |date=December 2011 |pmid=21384541 |pmc=4634648 |doi=10.1002/pbc.23090 |url=}}</ref>
***Lungs
***Liver
***Bone
***Brain 


==Prognosis==
===Prognosis===
It is highly responsive to treatment, with about 90% of patients surviving at least five years with appropriate treatment.
* Depending on various factors at the time of diagnosis, the prognosis may vary.<ref name="pmid26304882">{{cite journal |vauthors=Dome JS, Graf N, Geller JI, Fernandez CV, Mullen EA, Spreafico F, Van den Heuvel-Eibrink M, Pritchard-Jones K |title=Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration |journal=J. Clin. Oncol. |volume=33 |issue=27 |pages=2999–3007 |date=September 2015 |pmid=26304882 |pmc=4567702 |doi=10.1200/JCO.2015.62.1888 |url=}}</ref>
* However, the prognosis can be tumor recurrence or death. 
* These factors are:
** Histology of tumor
** Stage of the tumor
** Genetic and molecular markers
** Age of the patient
===== Histology of tumor =====
* 2 research groups have classified wilms tumor based on histology. These are:
**  National Wilms Tumor Study / Children's Oncology Group (NWTS/COG) .
** International Society of Pediatric Oncology (SIOP).
*  Prognosis is dependant on presence or absence of anaplasia.
*  If anaplasia is positive then it signifies a poor prognosis in children.<ref name="pmid2844645">{{cite journal |vauthors=Zuppan CW, Beckwith JB, Luckey DW |title=Anaplasia in unilateral Wilms' tumor: a report from the National Wilms' Tumor Study Pathology Center |journal=Hum. Pathol. |volume=19 |issue=10 |pages=1199–209 |date=October 1988 |pmid=2844645 |doi= |url=}}</ref><ref name="pmid6164480">{{cite journal |vauthors=D'Angio GJ, Evans A, Breslow N, Beckwith B, Bishop H, Farewell V, Goodwin W, Leape L, Palmer N, Sinks L, Sutow W, Tefft M, Wolff J |title=The treatment of Wilms' tumor: results of the Second National Wilms' Tumor Study |journal=Cancer |volume=47 |issue=9 |pages=2302–11 |date=May 1981 |pmid=6164480 |doi= |url=}}</ref>


==== Stage of the tumor ====
* Staging of wilms tumor is done on the basis of:<ref name="pmid16314292">{{cite journal |vauthors=Metzger ML, Dome JS |title=Current therapy for Wilms' tumor |journal=Oncologist |volume=10 |issue=10 |pages=815–26 |date=2005 |pmid=16314292 |doi=10.1634/theoncologist.10-10-815 |url=}}</ref>
** Genetics
** Histology
** Molecular markers
* Stage I (43% of patients)
** Outcome: 98% 4-year survival; 85% 4-year survival if [[anaplastic]]
* Stage II (23% of patients)
** Outcome: 96% 4-year survival; 70% 4-year survival if [[Anaplasia|anaplastic]]
* Stage III (23% of patients)
** Outcome: 95% 4-year survival; 56% 4-year survival if [[Anaplasia|anaplastic]]
* Stage IV (10% of patients)
** Outcome: 90% 4-year survival; 17% 4-year survival if [[Anaplasia|anaplastic]]


Patients with mutations in chromosomes 1q, 11q and 16q have a worse prognosis than those without these mutations.
==== Genetic and molecular markers ====
* Multiple genetic and molecular markers can predict prognosis.<ref name="pmid21189373">{{cite journal |vauthors=Perlman EJ, Grundy PE, Anderson JR, Jennings LJ, Green DM, Dome JS, Shamberger RC, Ruteshouser EC, Huff V |title=WT1 mutation and 11P15 loss of heterozygosity predict relapse in very low-risk wilms tumors treated with surgery alone: a children's oncology group study |journal=J. Clin. Oncol. |volume=29 |issue=6 |pages=698–703 |date=February 2011 |pmid=21189373 |pmc=3056654 |doi=10.1200/JCO.2010.31.5192 |url=}}</ref> <ref name="pmid18757319">{{cite journal |vauthors=D'Angio GJ |title=Pre- or postoperative therapy for Wilms' tumor? |journal=J. Clin. Oncol. |volume=26 |issue=25 |pages=4055–7 |date=September 2008 |pmid=18757319 |doi=10.1200/JCO.2008.16.5316 |url=}}</ref>
* These markers are:
** Loss of heterozygosity (LOH) at chromosomes:
*** 1p
*** 11p15
*** 16q
** Gain in :
*** 1q
* These markers are associated with increased risk of relapse and mortality.  


Survivors of this tumor are at risk for future malignancies especially leukemias and sarcomas arising either due to germline mutations or mutations acquired due to therapy for the primary tumor(Wilms’ tumor).
====Age of the patient====
* Patient with age lass than 2 years have a better prognosis.<ref name="pmid205340">{{cite journal |vauthors=Breslow NE, Palmer NF, Hill LR, Buring J, D'Angio GJ |title=Wilms' tumor: prognostic factors for patients without metastases at diagnosis: results of the National Wilms' Tumor Study |journal=Cancer |volume=41 |issue=4 |pages=1577–89 |date=April 1978 |pmid=205340 |doi= |url=}}</ref>
* As the patient gets old the treatment related complication rate also increases.<ref name="pmid15542800">{{cite journal |vauthors=Reinhard H, Aliani S, Ruebe C, Stöckle M, Leuschner I, Graf N |title=Wilms' tumor in adults: results of the Society of Pediatric Oncology (SIOP) 93-01/Society for Pediatric Oncology and Hematology (GPOH) Study |journal=J. Clin. Oncol. |volume=22 |issue=22 |pages=4500–6 |date=November 2004 |pmid=15542800 |doi=10.1200/JCO.2004.12.099 |url=}}</ref>


==References==
==References==
{{reflist|2}}
{{reflist|2}}
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Kidney diseases]]
[[Category:Kidney diseases]]
[[Category:Types of cancer]]
[[Category:Types of cancer]]
[[Category:Urology]]
[[Category:Urology]]
[[Category:Pediatrics]]
[[Category:Pediatrics]]
[[Category:Oncology]]
[[Category:Hematology]]
[[Category:Hematology]]
[[Category:Needs content]]

Latest revision as of 21:29, 11 June 2018

Wilms' tumor Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Wilms' Tumor from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography or Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Wilms' tumor natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Wilms' tumor natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Wilms' tumor natural history, complications and prognosis

CDC on Wilms' tumor natural history, complications and prognosis

Wilms' tumor natural history, complications and prognosis in the news

Blogs on Wilms' tumor natural history, complications and prognosis

Directions to Hospitals Treating Wilms' tumor

Risk calculators and risk factors for Wilms' tumor natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sargun Singh Walia M.B.B.S.[2]

Overview

The symptoms of wilms tumor usually develop in the first decade of life, and start with symptoms such as an abdominal/flank mass. If left untreated, patients with wilms tumor may progress to develop hypertension, anemia, weight loss, renal failure and metastasis. The overall 5-year survival rate is approximately 63% for patients aged 10 to 16 years. Depending on various factors at the time of diagnosis, the prognosis may vary. These factors are histology of tumor, stage of tumor, genetic and molecular markers and age of the patient.

Natural History, Complications, and Prognosis

Natural History

  • The symptoms of wilms tumor usually develop in the first decade of life, and start with symptoms such as an abdominal/flank mass.
  • If left untreated, patients with wilms tumor may progress to develop hypertension, anemia, weight loss, renal failure and metastasis.
  • The overall 5-year survival rate is approximately 63% for patients aged 10 to 16 years.

Complications

  • Common complications of wilms tumor include:
    • Hypertension
    • Anu
    • Anemia
    • Weight loss
    • Renal failure
    • Metastasis to:[1]
      • Lungs
      • Liver
      • Bone
      • Brain

Prognosis

  • Depending on various factors at the time of diagnosis, the prognosis may vary.[2]
  • However, the prognosis can be tumor recurrence or death.
  • These factors are:
    • Histology of tumor
    • Stage of the tumor
    • Genetic and molecular markers
    • Age of the patient
Histology of tumor
  • 2 research groups have classified wilms tumor based on histology. These are:
    •  National Wilms Tumor Study / Children's Oncology Group (NWTS/COG) .
    • International Society of Pediatric Oncology (SIOP).
  •  Prognosis is dependant on presence or absence of anaplasia.
  •  If anaplasia is positive then it signifies a poor prognosis in children.[3][4]

Stage of the tumor

  • Staging of wilms tumor is done on the basis of:[5]
    • Genetics
    • Histology
    • Molecular markers
  • Stage I (43% of patients)
    • Outcome: 98% 4-year survival; 85% 4-year survival if anaplastic
  • Stage II (23% of patients)
    • Outcome: 96% 4-year survival; 70% 4-year survival if anaplastic
  • Stage III (23% of patients)
    • Outcome: 95% 4-year survival; 56% 4-year survival if anaplastic
  • Stage IV (10% of patients)
    • Outcome: 90% 4-year survival; 17% 4-year survival if anaplastic

Genetic and molecular markers

  • Multiple genetic and molecular markers can predict prognosis.[6] [7]
  • These markers are:
    • Loss of heterozygosity (LOH) at chromosomes:
      • 1p
      • 11p15
      • 16q
    • Gain in :
      • 1q
  • These markers are associated with increased risk of relapse and mortality.

Age of the patient

  • Patient with age lass than 2 years have a better prognosis.[8]
  • As the patient gets old the treatment related complication rate also increases.[9]

References

  1. ↑ Termuhlen AM, Tersak JM, Liu Q, Yasui Y, Stovall M, Weathers R, Deutsch M, Sklar CA, Oeffinger KC, Armstrong G, Robison LL, Green DM (December 2011). "Twenty-five year follow-up of childhood Wilms tumor: a report from the Childhood Cancer Survivor Study". Pediatr Blood Cancer. 57 (7): 1210–6. doi:10.1002/pbc.23090. PMC 4634648. PMID 21384541.
  2. ↑ Dome JS, Graf N, Geller JI, Fernandez CV, Mullen EA, Spreafico F, Van den Heuvel-Eibrink M, Pritchard-Jones K (September 2015). "Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration". J. Clin. Oncol. 33 (27): 2999–3007. doi:10.1200/JCO.2015.62.1888. PMC 4567702. PMID 26304882.
  3. ↑ Zuppan CW, Beckwith JB, Luckey DW (October 1988). "Anaplasia in unilateral Wilms' tumor: a report from the National Wilms' Tumor Study Pathology Center". Hum. Pathol. 19 (10): 1199–209. PMID 2844645.
  4. ↑ D'Angio GJ, Evans A, Breslow N, Beckwith B, Bishop H, Farewell V, Goodwin W, Leape L, Palmer N, Sinks L, Sutow W, Tefft M, Wolff J (May 1981). "The treatment of Wilms' tumor: results of the Second National Wilms' Tumor Study". Cancer. 47 (9): 2302–11. PMID 6164480.
  5. ↑ Metzger ML, Dome JS (2005). "Current therapy for Wilms' tumor". Oncologist. 10 (10): 815–26. doi:10.1634/theoncologist.10-10-815. PMID 16314292.
  6. ↑ Perlman EJ, Grundy PE, Anderson JR, Jennings LJ, Green DM, Dome JS, Shamberger RC, Ruteshouser EC, Huff V (February 2011). "WT1 mutation and 11P15 loss of heterozygosity predict relapse in very low-risk wilms tumors treated with surgery alone: a children's oncology group study". J. Clin. Oncol. 29 (6): 698–703. doi:10.1200/JCO.2010.31.5192. PMC 3056654. PMID 21189373.
  7. ↑ D'Angio GJ (September 2008). "Pre- or postoperative therapy for Wilms' tumor?". J. Clin. Oncol. 26 (25): 4055–7. doi:10.1200/JCO.2008.16.5316. PMID 18757319.
  8. ↑ Breslow NE, Palmer NF, Hill LR, Buring J, D'Angio GJ (April 1978). "Wilms' tumor: prognostic factors for patients without metastases at diagnosis: results of the National Wilms' Tumor Study". Cancer. 41 (4): 1577–89. PMID 205340.
  9. ↑ Reinhard H, Aliani S, Ruebe C, Stöckle M, Leuschner I, Graf N (November 2004). "Wilms' tumor in adults: results of the Society of Pediatric Oncology (SIOP) 93-01/Society for Pediatric Oncology and Hematology (GPOH) Study". J. Clin. Oncol. 22 (22): 4500–6. doi:10.1200/JCO.2004.12.099. PMID 15542800.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Wilms%27_tumor_natural_history,_complications_and_prognosis&oldid=1476199"